Organogenesis Holdings Inc (NASDAQ: ORGO) is 69.06% higher on its value in year-to-date trading and has touched a low of $2.16 and a high of $6.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ORGO stock was last observed hovering at around $6.21 in the last trading session, with the day’s loss setting it -0.8%.
Currently trading at $5.41, the stock is 46.57% and 56.36% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.95 million and changing -12.88% at the moment leaves the stock 74.48% off its SMA200. ORGO registered 55.01% gain for a year compared to 6-month gain of 84.64%.
The stock witnessed a 43.50% loss in the last 1 month and extending the period to 3 months gives it a 36.62%, and is 70.13% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 20.56% over the week and 8.26% over the month.
Organogenesis Holdings Inc (ORGO) has around 869 employees, a market worth around $686.14M and $482.04M in sales. Current P/E ratio is 966.07 and Fwd P/E is 34.53. Profit margin for the company is 0.18%. Distance from 52-week low is 149.88% and -15.47% from its 52-week high. The company has generated returns on investments over the last 12 months (0.21%).
with sales reaching $90.77M over the same period.The EPS is expected to grow by 450.00% this year, but quarterly earnings will post -0.74% year-over-year. Quarterly sales are estimated to shrink -17.47% in year-over-year returns.
Organogenesis Holdings Inc (ORGO) Top Institutional Holders
The shares outstanding are 125.73M, and float is at 64.36M with Short Float at 13.47%.
The top institutional shareholder in the company is MORGAN STANLEY with over 11.58 million shares valued at $32.41 million. The investor’s holdings represent 8.7789% of the ORGO Shares outstanding. As of 2024-06-30, the second largest holder is SOLEUS CAPITAL MANAGEMENT, L.P. with 11.52 million shares valued at $32.25 million to account for 8.6888 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.09 million shares representing 3.8579% and valued at over $14.24 million, while ASSENAGON ASSET MANAGEMENT S.A. holds 2.9999 of the shares totaling 3.98 million with a market value of $11.14 million.
Organogenesis Holdings Inc (ORGO) Insider Activity
A total of 0 insider transactions have happened at Organogenesis Holdings Inc (ORGO) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by Gillheeney Gary S., the company’s President and CEO. SEC filings show that Gillheeney Gary S. sold 55,615 shares of the company’s common stock on Dec 13 ’24 at a price of $3.36 per share for a total of $0.19 million. Following the sale, the insider now owns 3.04 million shares.
Organogenesis Holdings Inc disclosed in a document filed with the SEC on Dec 16 ’24 that Gillheeney Gary S. (President and CEO) sold a total of 5,585 shares of the company’s common stock. The trade occurred on Dec 16 ’24 and was made at $3.49 per share for $19492.0. Following the transaction, the insider now directly holds 3.04 million shares of the ORGO stock.
Still, SEC filings show that on Dec 11 ’24, Gillheeney Gary S. (President and CEO) disposed off 157,448 shares at an average price of $3.64 for $0.57 million. The insider now directly holds 3,143,753 shares of Organogenesis Holdings Inc (ORGO).
